Collateral drug sensitivity induced in CPT-11 (a novel derivative of camptothecin)-resistant cell lines

This publication has 12 references indexed in Scilit:

• Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
  Published by Elsevier ,2021
• The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4′-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-0-ethylidene-β-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs
  Biochemical and Biophysical Research Communications, 1987
• CROSS-SENSITIVITY TO TOPOISOMERASE-II INHIBITORS IN CYTOTOXIC DRUG-HYPERSENSITIVE CHINESE-HAMSTER OVARY CELL-LINES
  1987
• DNA-POLYMERASES AND DNA TOPOISOMERASES AS TARGETS FOR THE DEVELOPMENT OF ANTICANCER DRUGS
  1986
• DNA topoisomerases as targets for cancer therapy
  Biochemical Pharmacology, 1985
• 4'-O-TETRAHYDROPYRANYLADRIAMYCIN AS A POTENTIAL NEW ANTI-TUMOR AGENT
  1982
• Biological studies on the degradation products of 3-[(S)-1'-phenylethylamino]propylaminobleomycin: A novel analog (pepleomycin).
  The Journal of Antibiotics, 1979
• New antitumor antibiotics, aclacinomycins A and B.
  The Journal of Antibiotics, 1975
• RESPONSE OF ACUTE LYMPHOCYTIC LEUKEMIAS TO THE PURINE ANTAGONIST 6‐MERCAPTOPURINE
  Annals of the New York Academy of Sciences, 1954
• GENETIC STUDIES ON MICROBIAL CROSS RESISTANCE TO TOXIC AGENTS I. ,
  Journal of Bacteriology, 1952